We conclude that the membrane-bound protein is osteoclast differentiation factor (ODF), a long-sought ligand mediating an essential signal to osteoclast progenitors for their differentiation into osteoclasts. ODF was found to be identical to TRANCE͞RANKL, which enhances T-cell growth and dendritic-cell function. ODF seems to be an important regulator in not only osteoclastogenesis but also immune system.
Hemopoietic precursor cells differentiate into osteoclasts at bone-resorbing sites under the control of osteotropic hormones and local factors produced in the microenvironment (1) (2) (3) (4) . We previously established a cell culture system to produce osteoclast-like cells (OCLs) using cocultures of spleen cells and osteoblasts or bone marrow stromal cells (5, 6) . In the cocultures, OCLs are formed from spleen cells in the presence of such stimulators of bone resorption as interleukin 6 (IL-6), IL-11, parathyroid hormone (PTH), prostaglandin E 2 (PGE 2 ), and 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] (1-3, 5, 6). These stimulators are classified into three categories in terms of signal transduction pathways: vitamin D receptor-mediated signals [1, 25(OH) 2 D 3 ]; protein kinase A-mediated signals (PTH and PGE 2 ); and gp130-mediated signals (IL-6 and IL-11). They appear to transduce the signals that induce osteoclastogenesis to osteoblasts͞stromal cells (1) (2) (3) . No OCLs are formed, even in the presence of 1,25(OH) 2 D 3 , when the cocultures of osteoblasts͞stromal cells and spleen cells are separated with a membrane filter (5-7). These observations indicated that osteoblasts͞stromal cells are essential for in vitro osteoclastogenesis through a cell-to-cell interaction (1) (2) (3) . Thus, we proposed a hypothetical membrane-bound factor(s) that is expressed on osteoblasts͞stromal cells in response to the stimulators of bone resorption and induces osteoclastogenesis by signaling to osteoclast progenitors. We named the factor ''osteoclast differentiation factor (ODF)'' (1) (2) (3) .
Recently, we reported the purification of osteoclastogenesisinhibitory factor (OCIF) from conditioned medium of human fibroblasts (8) . OCIF specifically inhibits in vitro OCL formation elicited through the three distinct signaling pathways stimulated by 1,25(OH) 2 D 3 , PTH, or IL-11 (8) . The nucleotide sequence analysis of OCIF cDNA (9) has demonstrated that OCIF is identical to osteoprotegerin (OPG) (10) , which was initially identified as a novel secreted member of the tumornecrosis factor (TNF) receptor family in an expressed sequence tag cDNA project (10) . The analyses of transgenic mice overexpressing OPG͞OCIF and animals injected with OPG͞ OCIF have demonstrated that OPG͞OCIF suppresses bone resorption associated with osteoclast development (9, 10) . OPG͞OCIF lacks apparent transmembrane domain (9, 10) and seems to act as a soluble inhibitory receptor in osteoclastogenesis.
A mouse bone marrow-derived stromal cell line, ST2, is known to support OCL formation from mouse spleen cells in the presence of 1,25(OH) 2 D 3 and dexamethasone (Dex) (6) . We have recently reported that OPG͞OCIF specifically binds to ST2 cells treated with 1,25(OH) 2 D 3 and Dex, but not to untreated ST2 cells (8, 9) . When the binding sites on the treated ST2 cells were occupied by OPG͞OCIF, the cells failed to support OCL formation from spleen cells (9) . Cross-linking study using [ 125 I]OPG͞OCIF revealed that a 40-kDa protein on the treated ST2 cells binds to OPG͞OCIF (9) . These results raised the possibility that the binding protein of 40 kDa is a
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ligand for OPG͞OCIF and identical to ODF. Thus, we screened a cDNA expression library of ST2 cells treated with 1,25(OH) 2 D 3 and Dex to isolate the cDNA encoding the OPG͞OCIF binding protein. Here we report that the protein is a member of the membrane-associated TNF ligand family and has characteristics that satisfy the major criteria of ODF.
MATERIALS AND METHODS
Cell Culture. ST2 cells (Riken Cell Bank, Tsukuba) were cultured in ␣-minimal essential medium (MEM) (GIBCO͞ BRL) containing 10% fetal calf serum (FCS). COS-7 cells (Riken Cell Bank) were cultured in Dulbecco's modified eagle's medium (DMEM; GIBCO͞BRL) containing 10% FCS. C7 cells, which were a generous gift from S.-I. Hayashi (Tottori University, Yonago), were cultured in ␣-MEM containing 10% FCS and 1 ng͞ml of human macrophage colonystimulating factor (M-CSF) (Green Cross, Osaka).
cDNA Cloning. A cDNA expression library in pcDL-SR␣296 (11) was constructed using Great Lengths cDNA synthesis kit (CLONTECH) from poly(A) ϩ RNA of ST2 cells cultured in the presence of 10 Ϫ8 M of 1,25(OH) 2 D 3 and 10
Ϫ7
M of Dex for 5 days. The resulting ST2 expression library was plated onto 24-well plates at a density of Ϸ100 bacterial colonies per well. Subpools of plasmid DNA were prepared from each bacterial plate using a Qiawell plasmid purification system (Qiagen, Chatwsworth, CA) and were transfected into COS-7 cells grown in 24-well plates using Lipofectamine (GIBCO͞BRL). Transfectants were cultured for 2 days and incubated with 3 ϫ 10 5 cpm of [ 125 I]OPG͞OCIF at 37°C for 1 h as described (9) . A positive pool obtained was partitioned into smaller subpools until a single cDNA clone, designated pOBM291, was isolated. The cDNA was sequenced using AmpliTaq DyeDeoxy Terminator Cycle Sequencing on an ABI 377 sequencer (PerkinElmer). For the binding analysis using [ 125 I]OPG͞OCIF, COS-7 cells transfected with pOBM291 (the ODF expression vector) or pcDL-SR␣296 (the empty vector) were cultured for 2 days, and then incubated with 1 nM of [ 125 I]OPG͞OCIF (1 ϫ 10 6 cpm) at 37°C for 1 h in the presence or absence of 400 nM of unlabeled OPG͞OCIF as described (9) .
Preparation of a Soluble ODF (sODF). sODF was prepared by fusing the extracellular domain of ODF (Asp 76 -Asp
316
) to the C-terminal end of thioredoxin using ThioFusion Expression System (Invitrogen). A DNA fragment encoding the extracellular domain of ODF was prepared by digesting pOBM291 with BamHI and EcoRI. PCR was performed using ODF cDNA as a template to amplify the 3Ј portion of the cDNA with the following two primers: 5Ј-ATCAGAAGAC-AGCACTCACT-3Ј and 5Ј-GGGGTCGACCTAGGACATC-CATGCTAATGTTCC-3Ј. The PCR product was then digested with SalI and EcoRI and a 160-bp fragment was isolated. The BamHI-EcoRI and SalI-EcoRI fragments and pTrxFus vector digested with BamHI and SalI were ligated to yield pTrx-ODF. An Escherichia coli strain GI724 was transformed with pTrx-ODF. sODF was purified from the soluble cytoplamic fraction of the transformants by affinity chromatography on an OPG͞OCIF-immobilized column and by gel filtration chromatography.
Expression and Molecular Characterization of Full-Length ODF. COS-7 cells transfected with the ODF expression vector or the empty vector were cultured for 2 days. The cells were pulse-labeled with 0.2 mCi͞ml (1 Ci ϭ 37 Gbq) Express Protein Labeling Mix (NEN) for 4 h in cysteine-methioninefree medium, washed twice with PBS, and lysed in 10 mM of Tris⅐HCl, pH 8.0, containing 1% Triton X-100, 0.14 M of NaCl, 0.1% bovine hemoglobin, and protease inhibitors (12) . After removal of cell debris by centrifugation, the lysates (100 l) were incubated with or without 1 g of OPG͞OCIF for 1 h at 4°C. Five micrograms of anti-OPG͞OCIF or mouse immunogloblin (IgG) was added to the mixture and the complexes formed were bound to protein A-Sepharose gel. OPG͞OCIF-associated immunoprecipitates were analyzed on a 12.5% SDS͞polyacrylamide gel under reducing conditions. OCL Formation Assay. COS-7 cells transfected with the ODF expression vector or the empty vector were cultured for 2 days on coverslips in a 24-well plate, fixed in PBS containing 1% paraformaldehyde for 8 min at room temperature, and washed four times with PBS. Mouse spleen cells (7 ϫ 10 5 cells) obtained from 6-to 15-week-old male ddY mice (6) were cultured for 6 days either on the fixed cells in ␣-MEM containing 10% FCS and 10 ng͞ml of human M-CSF or in the same medium in the presence or absence of various concentrations of sODF in a 24-well plate. After treatment, the cells were subjected to tartrate-resistant acid phosphatase (TRAP) staining, calcitonin binding, and autoradiography. For TRAP staining, the cells were fixed and stained for acid phosphatase in the presence of 50 mM of sodium tartrate (6) . Dentine Resorption Assay. Spleen cells (2 ϫ 10 7 cells) were cultured in ␣-MEM containing 10% FCS, 10 ng͞ml of M-CSF, and 30 ng͞ml of sODF for 6 days in a 10-cm dish. The cultured cells were recovered from the culture with a scraper and were collected by centrifugation. The cells (1 ϫ 10 5 cells) were cultured for additional 3 days on dentine slices in the same medium. After removal of the cells, the slices were stained with Mayer's hematoxylin to visualize resorption pits (13) .
Binding Analysis of [ 125 I]sODF to C7 Cells. Radioiodination of sODF with [ 125 I]Bolton-Hunter Reagent (NEN) was performed as described (14) . C7 cells (1 ϫ 10 5 cells) were cultured in a 24-well plate. Binding analysis was performed by incubating C7 cells with 1.0 ϫ 10 6 cpm of [ 125 I]sODF for 1.5 h at 37°C in the presence or absence of 400-fold excess unlabeled sODF as described previously (9) .
Northern Blot Analysis. Isolation of total RNA and hybridization were done as described (15) . Poly(A) ϩ RNA was isolated from total RNA using an oligo(dT) cellulose spin column. A blot contained 2 g per lane of poly(A) (Fig. 4C) . Other blots contained 20 g per lane of total RNA (Fig. 4 A and B) . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as an internal control.
Preparation of Primary Osteoblasts. Primary osteoblasts were prepared from calvaria of newborn ddY mice as described (16) . The osteoblasts were cultured in ␣-MEM containing 10% FCS in the presence of 10 Ϫ8 M of 1,25(OH) 2 D 3 , 10
Ϫ8
M of IL-11, 10 Ϫ6 M of PGE 2 , or 5 ϫ 10
M of PTH for 6 days and subjected to the isolation of RNA.
RESULTS
Cloning of Mouse ODF cDNA. By screening a cDNA expression library of ST2 cells treated with 1,25(OH) 2 D 3 and Dex using [ 125 I]OPG͞OCIF, a cDNA clone, designated pOBM291, was isolated from Ϸ5 ϫ 10 4 colonies. pOBM291 contained a 1.65-kb insert with an ORF encoding 316 amino acids (M r 36K) (Fig. 1A) . Hydropathy analysis showed the absence of a signal sequence and the presence of an internal 24-residue hydrophobic domain, which presumably represents a transmembrane domain. This structure is typical of a type II Fig. 1B , OPG͞OCIF specifically bound to COS-7 cells expressing ODF (COS ODF ), but not to control COS-7 cells transfected with the empty vector (COS Vec ). To determine molecular weight of ODF, we pulse-chase labeled COS ODF cells and coimmunoprecipitated the cell lysates with anti-OPG͞OCIF antibody in the presence of OPG͞OCIF. The results demonstrated that ODF is a 40-kDa protein (Fig. 1C) .
Biological Function of ODF. To examine whether ODF mediates a cell-to-cell signal responsible for osteoclastogenesis, we carried out an in vitro OCL formation assay by evaluating TRAP activity and calcitonin binding, a combination of which is unique to osteoclasts (1, 22 
sODF Induces OCL Formation From Spleen Cells in the Absence of Osteoblasts͞Stromal Cells. The results from the experiments using COS ODF cells did not exclude the possibility that other proteins co-expressed on COS ODF cells might be involved in the signaling for osteoclastogenesis. Therefore, we next examined the effect of sODF, which is produced by fusing the extracellular domain of ODF to thioredoxin, on in vitro OCL formation. When mouse spleen cells were cultured in the presence of 10 ng͞ml of M-CSF and various concentrations of sODF, TRAP-positive multinucleated cells were formed in a dose-dependent manner (Fig. 2 A and B) . In the cocultures, giant TRAP-positive cells were formed in the presence of 30 ng͞ml of sODF and the cells with numerous nuclei ranged in size up to 500 m in diameter (Fig. 2 A) . Strong TRAP stain was observed in the periphery of the nuclei. The morphological (Fig. 2C) . OPG͞OCIF negated the effect of sODF in a dose-dependent manner (data not shown). Furthermore, when these OCLs were cultured on dentine slices for 3 days in the presence of M-CSF and sODF, numerous resorption pits were formed on the slices (Fig. 2D) .
sODF Acts Directly on Osteoclast Progenitors. Mature monocytes and alveolar macrophages as well as several cell lines of the macrophage lineage can differentiate into OCLs, when cocultured with stromal cells in the presence of 1,25(OH) 2 D 3 (23) (24) (25) . A macrophage cell line, C7, is also capable of differentiating into OCLs in such a coculture system (26) . Because spleen cells are a mixture of hematopoietic cell and stromal cell populations, we used C7 cells to examine whether ODF acts directly on osteoclast progenitors. sODF induced the formation of TRAP-positive multinucleated cells from C7 cells in a dose-dependent manner in the presence of M-CSF (Fig. 3A) . The TRAP-positive multinucleated cells formed from C7 cells were morphologically similar to those formed from spleen cells in the presence of M-CSF and sODF ( 
Ϫ7
M of Dex, which is known to show a maximal effect on OCL formation in the cocultures of spleen cells and bone marrow stromal cells (6) , gave the highest up-regulation of the ODF gene expression (Fig. 4A) . Up-regulation of the ODF gene expression was also observed in mouse primary osteoblasts cultured in the presence of 1,25(OH) 2 D 3 , IL-11, PGE 2 , or PTH (Fig. 4B) . The up-regulation of ODF expression was consistent with the observation that the binding of [ (data not shown). OPG͞OCIF inhibited OCL formation elicited by each stimulator in the cocultures of spleen cells and osteoblasts (data not shown). Analysis of tissue distribution of the ODF transcript showed that the gene was strongly expressed in trabecular bone, thymus, and lung, and weakly expressed in spleen and bone marrow (Fig. 4C) .
DISCUSSION
During the past decade, we demonstrated that a cell-to-cell contact between osteoblasts͞stromal cells and osteoclast progenitors is important for osteoclastogenesis (1-3, 5, 6) . In the present study we molecularly cloned a mouse OPG͞OCIF-binding protein and identified it as ODF (1-3) , the longsought-after factor essential for osteoclastogenesis. The following evidence demonstrates that ODF is expressed on the membrane of osteoblasts͞stromal cells in response to three distinct bone-resorbing signals and mediates an essential signal to osteoclast progenitors for their differentiation into osteoclasts: (i) the fixed COS ODF cells induced the OCL formation from spleen cells; (ii) sODF induced the OCL formation from spleen cells or C7 cells in the absence of osteoblasts͞stromal cells, and these OCLs were capable of forming numerous pits on dentine slices; (iii) the three distinct signals, through vitamin D receptor, protein kinase A, and gp130, independently up-regulated the expression of ODF gene in osteoblasts and induced ODF on the membrane; and (iv) the specific binding of [ 125 I]sODF to C7 cells suggested the direct action of ODF on osteoclast progenitors of the monocyte͞macrophage lineage.
Because ODF is identified as an OPG͞OCIF binding protein, it is important to understand the relationship between ODF and OPG͞OCIF. In the present study, we demonstrated that OPG͞OCIF specifically abolishes the effect of both membrane-bound-and soluble-form ODF. OPG͞OCIF also inhibited the OCL formation elicited through the three distinct signaling pathways in cocultures of spleen cells and osteoblasts, as it did in the culture of unfractionated bone cells or cocultures of spleen cells and stromal cell lines (8) . These results strongly suggest that OPG͞OCIF inhibits in vitro osteoclastogenesis by directly binding to ODF on osteoblasts͞stromal cells and eventually interrupting ODF-mediated signaling from osteoblasts͞stromal cells to osteoclast progenitors. On the analogy of the TNF ligand family that interacts with a parallel TNF receptor family (17) (18) (19) , we suspect that OPG͞OCIF acts as a soluble form competitor of ODF receptor presumably expressed on osteoclast progenitors (see below).
M-CSF produced by osteoblasts͞stromal cells appears to be essential for the proliferation and differentiation of osteoclast progenitors (27) (28) (29) (30) (31) . This is consistent with our observation that M-CSF was indispensable for ODF-mediated OCL formation. The concentration of M-CSF seems to be crucial for ODF-mediated OCL formation. A high concentration of M-CSF (Ն40 ng͞ml) suppressed OCL formation from sODFstimulated spleen cells (N.S., unpublished observation). Perkins and Kling (32) also reported that addition of exogenous M-CSF to the cocultures of ST2 cells and spleen cells causes a dose-dependent decrease in the number of OCLs accompanied by an increase in the number of macrophage. These results suggest that not only ODF expression but also local concentrations of M-CSF influence osteoclast differentiation. We previously reported that the expression of OPG͞OCIF gene in ST2 cells is down-regulated by 1,25(OH) 2 D 3 and up-regulated by calcium ions (9). In addition, the level of OPG͞OCIF expression in trabecular bones of ovariectomized rats decreased to 60% of that of sham-operated rats (H.Y., unpublished observation). These results imply a possible role of OPG͞OCIF as a local regulator for osteoclastogenesis. Northern blot analysis revealed that ODF gene was highly expressed in not only osseous tissues but also nonosseous tissues such as thymus and lung. At present, we cannot explain why osteoclasts are not seen in nonosseous tissues expressing a high level of ODF mRNA. The microenvironment suitable for osteoclastogenesis seems to require a balance in the local concentrations of M-CSF and OPG͞OCIF, presence of osteoclast progenitors, and ODF expression on osteoblast͞stromal cells.
During the preparation of this manuscript, a new member of the TNF ligand family designated TRANCE (20) or RANK ligand (RANKL; ref. 21 ) was independently cloned. Analysis of the predicted amino-acid sequence revealed that ODF is identical to TRANCE͞RANKL. TRANCE was identified as an activator of c-Jun N-terminal kinase in T-cells. TRANCE is abundantly expressed in T cells but not in B cells. RANKL was identified as a ligand for RANK, a new member of the TNF receptor family derived from dendritic cells. RANKL activates NF-B and enhances T cell growth and dendritic cell function. Together, TRANCE͞RANKL͞ODF seems to be an important regulator of T cells, dendritic cells, and osteoclasts. It should be noted that both dendritic cells and osteoclasts are generated from hematopoietic cells of the monocytemacrophage lineage (33) . Recently, Iotsova et al. (34) reported that NF-B1 and NF-B2 double-knockout mice develop osteopetrosis because of a defect of osteoclast differentiation. This report suggests that the activation of NF-B is important for osteoclastogenesis. Taken all together, these observations imply the identity of RANK with ODF receptor. The mechanism by which ODF mediates signals to osteoclast progenitors through a possible ODF receptor, RANK, should be elucidated. We found that the expression of the TRANCE͞ RANKL͞ODF gene is up-regulated by osteotropic factors, including 1,25(OH) 2 D 3 . Vitamin D and other osteotropic factors may also be involved in the TRANCE͞RANKL͞ODF-mediated immune responses. Our findings appear to give an insight into the understanding of the potential immunological roles of vitamin D (35) .
The present study indicates that osteoblasts͞stromal cells play an essential role in osteoclastogenesis through the expression of ODF on the membrane (Fig. 5) . Identification of ODF as TRANCE͞RANKL and as a ligand for OPG͞OCIF raises the possibility that ODF and OPG͞OCIF are involved in the regulation of not only osteoclastogenesis but also immune system. Further characterization of TRANCE͞RANKL͞ ODF, OPG͞OCIF, and the possible ODF receptor, RANK, will shed light on osteoclast biology and immunology. 
